Pfizer Total Current Liabilities 2010-2024 | PFE

Pfizer total current liabilities for the quarter ending June 30, 2024 were $43.819B, a 26.47% increase year-over-year.

  • Pfizer total current liabilities for 2023 were $47.794B, a 13.42% increase from 2022.
  • Pfizer total current liabilities for 2022 were $42.138B, a 1.25% decline from 2021.
  • Pfizer total current liabilities for 2021 were $42.671B, a 64.63% increase from 2020.

Pfizer Total Current Liabilities 2010-2024 | PFE

  • Pfizer total current liabilities for 2023 were $47.794B, a 13.42% increase from 2022.
  • Pfizer total current liabilities for 2022 were $42.138B, a 1.25% decline from 2021.
  • Pfizer total current liabilities for 2021 were $42.671B, a 64.63% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B